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Background. Pain after Caesarean delivery is partly related to Pfannenstiel incision, which can be inﬁltrated with local anaesthetic
solutions.Methods.Adouble-blindrandomizedcontroltrialwasdesignedtoassesstheanalgesiceﬃcacyof7.5mg/mLropivacaine
solution compared to control group, in two groups of one hundred and forty four parturients for each group, who underwent
Caesareansectionunderspinalanaesthesia:groupR(ropivacainegroup)andgroupC(controlgroup).Allparturientsalsoreceived
spinal sufentanil (2.5μg). Results.Ropivacaine inﬁltration in the Pfannenstiel incision for Caesarean delivery beforewound closure
leads to a reduction of 30% in the overall consumption of analgesics (348550mg for group R versus 504426mg for group C with
P<. 05), especially opioids in the ﬁrst 24 hours, but also signiﬁcantly increases the time interval until the ﬁrst request for an
analgesic (4h 20min ± 2h2 6f o rg r o u pRv e r s u s2h4 2± 1h30 for group C). The P values for the two groups were: P<. 0001 for
paracetamol, P<. 0001 for ketoprofen and P for nalbuphine which was the most signiﬁcant. There is no signiﬁcant diﬀerence in
the threshold of VAS in the two series. Conclusion. This technique can contribute towards a programme of early rehabilitation in
sectioned mothers, with earlier discharge from the post-labour suite.
1.Introduction
The number of Caesarean sections is increasing progressively
in European countries with the aim of improving fetal pro-
gnosis; about 20% of deliveries are performed under Cae-
sarean section [1, 2]. Caesarean section commonly induces
moderate to severe pain lasting 48 hours [3–5]. Opioids
are commonly used for relief of postoperative pain after
Caesarean section, either by intrathecal administration prior
to section or parenteral administration postoperatively.
The addition of opioids intrathecally prolongs the eﬀects
of the spinal anaesthesia and reduces the dose of local
anaesthetic required, thus reducing the hemodynamic eﬀects
whicharedeleterioustothefetus.However,toobtainanalge-
sia of good quality and of long duration then higher doses of
opioids have to be used. But the risk of complications such as
respiratory depression, urinary retention, pruritus, nausea,
and vomiting can preclude patient’s comfort [6–9].
Ontheotherhand,nonopioidsystemicanalgesicsarenot
powerful enough to allow eﬀective pain control after Cae-
sarean section [10, 11]. Other techniques of postoperative
analgesia, such as epidural morphine or local anaesthetics
also have limits because they require prolonged clinical
surveillance.
The aim of this study is to examine the quality of anal-
gesia provided by the inﬁltration of a solution of 7.5mg/mL
ropivacaine in Pfannenstiel incision for Caesarean sections
by analysing the overall analgesic consumption of both
opioid and nonopioid agents, in the ﬁrst 24 postoperative
hours, in order to show whether ropivacaine inﬁltration
leads to a reduction in the need for postoperative analgesic
medication.
2. Methods
A total of two hundred and eighty eight ASA 1 parturients,
who underwent elective Caesarean section under spinal
anaesthesia, were included in this prospective double-blind
randomised control study. Parturients were excluded from
the study if they had an emergency procedure or if the2 Anesthesiology Research and Practice
procedure was performed under general or epidural anaes-
thesia,oriftheyhadacontraindicationtotheadministration
of nonsteroidal anti-inﬂammatory drugs (NSAID’s).
The study received the approval of the ethical committee
and parturients were included after written informed con-
sent. Parturients were assigned randomly into two groups:
group R (ropivacaine group) and group C (control group).
Randomisation was performed using random number allo-
cation and sealed envelopes, and each group consisted of one
hundred and forty four parturients.
Spinal anaesthesia was performed at L3-L4 with 8–10mg
of a hyperbaric bupivacaine 5mg/mL solution, according to
the height of the patient (8mg for patients measuring from
1m50to1m59,9mgforpatientsfrom1m60to1m69,and
10mg for patients taller than 1m70). The administration of
sufentanil 2.5μg was standardized for all the patients.
A urinary catheter was inserted systematically before the
Caesarean section and was left in place for 24 hours.
All Caesarean sections were performed using a Pfannen-
stiel incision, with peritoneal opening. Before skin closure,
inﬁltration with 30mL of ropivacaine 7.5mg/mL (225mg)
was performed in group R: 10mL for the aponeurosis and
10mL subcutaneously on each of the upper and lower
edges of the incision, using a 30mL syringe and a 23G
subcutaneous needle. This inﬁltration in three distinct parts
was chosen to standardize the practice and reduce operator-
related diﬀerences, since six surgeons participated in the
operations. Group C did not receive any inﬁltration before
skin closure.
In both groups further postoperative analgesia was
administeredintherecoveryroomorinthepost-laboursuite
when pain score, evaluated systematically every 2 hours and
at every analgesic request by the patient, was ≥4 on the VAS.
Initially, paracetamol 1gIV was administered when the
patients complained of pain and then repeated every 6 hours
over 24 hours. Intravenous ketoprofen at a dose of 3mg/kg
was administered secondarily every eight to twelve hours,
when the patients requested further pain relief and if the
VAS ≥4, and when paracetamol administration alone was
ineﬀective. If this regimen was insuﬃcient, nalbuphine 15–
20mg was given intravenously over one hour every 6 hours.
3. Statistics
From our previous experience (and data in the literature)
we calculated that a number of one hundred and forty four
patients in each arm was necessary, assuming a signiﬁcant
diﬀerence of 30% or more in systemic analgesic consump-
tion, with a type I error of 0.05 and a power of 0.9. Data were
analyzed using the Statistical Package for the Social Science
Version (SPSS for Windows, release 10.0; SPSS, Chicago,
IL). A Kolmogorov-Smirnov test was used, and stratiﬁed
distribution plots were examined to verify the normality of
distribution of continuous variables. Baseline characteristics
(age, gender, duration of surgery, duration of anaesthesia,
ASA scores, weight, height, and BMI) and the delay before
rescue analgesic were compared across treatment groups
using 2-way analysis of variance or the Fischer’s exact test.
The number of patients receiving rescue analgesics at a
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Figure 1: Interval before the ﬁrst analgesic administration (Pain
free interval).
ﬁxed interval was analyzed by a 2-way ANOVA and post hoc
comparisons at various times using Bonferroni’s type I error
correction for multiple comparisons. Data were expressed as
mean ± SD. The level of signiﬁcance was set at P<. 05. No
adaptive interim analysis was performed during the study.
4. Results
P a r t u r i e n t si nt h et w og r o u p sw e r ec o m p a r a b l ef o rd e m o -
graphics and VAS scores (Table 1). All patients enrolled
completed the study.
The comparative analysis was carried out between the
two groups for each type of analgesic administered, taking
as a reference point the moment when the spinal anaesthesia
was performed, the request for analgesics and VAS scores by
blocksoftwohours,theoverallconsumptionforeachtypeof
analgesic, and for all three types of analgesics overall (Tables
2 and 3 and Figure 1).
The percentage of parturients who requested the ﬁrst
dose of intravenous paracetamol is identical in the two
groups. The percentage of patients who were given paraceta-
mol was signiﬁcantly less on the second and the third time
of administration in the ropivacaine group. The percentage
of patients who received ketoprofen was also lower in the
ropivacaine group at the second and the third time of
administration as well as the percentage of patients who
requestednalbuphineatthecorrespondingintervals(Figures
2 and 3).
In both groups, the nurse in charge of each patient
monitored the ventilation, the presence of nausea and
vomiting, of paralytic ileus and pruritis during the ﬁrst 24
postoperative hours and recorded her ﬁndings on a chart.
Spontaneous ventilation monitored by a pulse oximeter
for the ﬁrst 6 postoperative hours detected no sign of
postoperative respiratory depression. No case of nausea or
vomiting was reported in the ﬁrst 24 hours, either during
fasting or after reintroduction of food, 8 hours after surgery,
which was well tolerated by all the patients. No sign of
abdominal distension or of absence of intestinal transit wasAnesthesiology Research and Practice 3
Table 1: Parturient’s demographics and VAS scores evaluated every 2 hours.
age (year) height (cm) weight before pregnancy (kg) BMI VAS
Ropivacaine group 31.7 ± 5.5 159.7 ± 6.8 66.6 ± 14.1 25 ± 65 . 2 ± 1.6
Control group 32.25 ± 5.4 161.4 ± 6.2 67.0 ± 14.9 26 ± 55 ± 1.4
P = .22 .06 .41 .12 .10
Non signiﬁcant NS NS NS NS NS
Table 2: Statistical Analysis (1).
Ropivacaine Group Control Group
Type of Analgesic Number of
patients
Analgesics over
24h (mg)
Mean
VAS
Standard
deviation
Number of
patients
Analgesics over
24h (mg)
Mean
VAS
Standard
deviation
Dose 1 144 144000 5.2 2:26 144 144000 5 2:42
Paracetamol Dose 2 127 127000 5.6 2:17 143 143000 5.6 2:55
Dose 3 52 52000 5.5 5:06 124 124000 5.5 4:09
Dose 4 4 4000 4 1:34 65 65000 5.4 2:36
TOTAL X 327000 5.0 2:50 X 476000 5.4 3:05
Dose 1 139 13900 5.7 3:58 143 14300 5.8 3:22
Ketoprofen Dose 2 73 7300 5.6 0:26 125 12500 5.9 3:49
Dose 3 1 100 5 0:00 10 1000 5.5 6:12
TOTAL X 21300 5 1:48 X 27800 5.7 4:27
Dose 1 114 180 6.2 4:34 141 250 6 17:26
Nalbuphine Dose 2 32 50 6.1 4:18 129 220 6.1 5:48
Dose 3 1 20 7 0:00 81 132 5.7 5:41
Dose 4 0 0 0 0:00 16 24 5 11:22
TOTAL X 250 6 4:26 X 626 5.7 10:04
TOTAL OVERALL 144 348550 5.6 3:01 144 504426 5.6 5:52
Table 3: Statistical analysis (2).
Ropivacaine
Group
Control
Group P
Mean VAS 5.2 5 NS
Mean time interval to ﬁrst
analgesic request (hours) 04:20 02:42 <.001
Standard deviation 02:26 01:30
Analgesic consumption (mg) 348 550 504 426 <.0014 Anesthesiology Research and Practice
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Figure 2: Percentage of patients needing analgesic administration over 24 hours.
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Figure 3: Postoperative analgesic consumption.Anesthesiology Research and Practice 5
recordedbythenursingstaﬀ.Nocaseofpruritiswasreported
by the patients.
The urinary catheter was removed at the 24th postoper-
ative hour and normal bladder function resumed with no
case of urinary retention noted among the 288 patients in
our study.
5. Discussion
This study documents that surgical incision inﬁltration with
ropivacaine 7.5mg/mL signiﬁcantly prolongs by 2 hours and
26 minutes the pain-free interval after Caesarean section and
decreases the rescue analgesic demand by 30% (Figures 1, 2
and 3).
Previousstudieshavedemonstratedthatlocalanaesthetic
inﬁltration was eﬀective after parietal surgery such as
inguinal hernia repair [12–16].
In 1998 Moiniche et al. published a series of ﬁve studies
concerning incisional local anaesthesia for postoperative
pain relief after abdominal operations [17]. All these studies
showed that pain scores were reduced with VAS decreased by
around 25–50mm.
In three studies, the pain scores were reduced after
surgery, from 1 to a maximum 4 hours. In the study carried
out by Sinclair et al., the pain scores were reduced in the
ﬁrst 24 hours, but not from the 24th to 48th hour [18]. In
the study by Tverskoy et al., pain scores were reduced up
until 48th hour after surgery [19]. In the four studies in
which the time interval from inﬁltration to the ﬁrst request
for analgesics was evaluated, the duration of analgesia was
signiﬁcantly prolonged at 2–7 hours. Thereafter, Tverskoy et
al. used a ﬁxed analgesic regimen in their study design, but in
the four other studies a signiﬁcant reduction (approximately
50%) in supplementary analgesic consumption was found
compared to the control group.
Other studies have previously demonstrated that inci-
sional inﬁltration was eﬀective after Caesarean section
[20, 21]. In addition the technique is safe since several
studies have demonstrated that the plasma concentration of
ropivacaine remains below the toxic threshold provided the
dose is limited to less than 300mg [15, 22].
One may argue that spinal sufentanil and/or morphine
may ensure eﬀective analgesia without the need for an
alternative technique such as abdominal wall inﬁltration.
However, the hydrosolubility of morphine leads to its pro-
longed presence in the cerebrospinal ﬂuid with eﬀects lasting
from 18 to 24 hours. It slowly penetrates the spinal cord
and the dorsal horn [23, 24] thus there is a risk of delayed
respiratory depression because of cephalic spread as well as
othersecondaryeﬀectssuchasnausea,vomiting,andpruritis
[6, 7, 25]. Spinal opioids not only produce side eﬀects, but in
the dose range that is acceptable, cannot guarantee 24 hour
analgesia [26, 27]. The inﬁltration of local anaesthetics at the
surgical incision allows us to use a lower dose of intrathecal
morphineandsolimititssideeﬀects.Forthisreasonweused
sufentanilat the dose of 2.5μg, despite its shorter duration of
action compared with either morphine or fentanil.
From the 1980s morphine has been used by epidural
injection after Caesarean section in doses from 2 to 8mg
[28, 29]. However epidural administration of morphine
frequently leads to pruritis, nausea, and vomiting, even
with doses <1,25mg [28–30]. Respiratory depression is
the complication which has the greatest risk, its frequency
being proportional to the dose administered. In the study
by Writer et al. in 1985, respiratory depression was observed
in 7% of patients who received 5mg of morphine by the
epidural route, which imposes prolonged monitoring of
ventilation up to 24 hours after the injection [31]. Some
hospitals cannot provide such surveillance, and so the use of
this technique is limited.
The technique of PCEA with low dose of ropivacaine
limits patient mobility because of the encumbrance of the
machines used and so is not a technique of choice in our
practice.
The TAP block is not within the capability of all
anaesthesiologists, as it requires initiation and experience
in the technique. Its use is also limited because of the risk
of intraperitoneal injection or lesions of intraabdominal
organs, as described by Farooq and Carey [32], and Jankovic
et al. [33]. Echo-guided TAP block gives more security but
requires the availability of an echograph in the obstetrical
operating room.
Since the beginning of the 90s, many studies have been
carriedoutonthequalityofpostoperativeanalgesiaobtained
with continuous infusions, instillations and, more recently,
inﬁltrations of ropivacaine in surgical wounds [34–36].
T h e s en e wt e c h n i q u e sh a v el e dt oab e t t e rq u a l i tyo fa n a l g e s i a
and a signiﬁcant decrease in the consumption of systemic
analgesics in the ﬁrst 24 postoperative hours.
Incisional inﬁltration also has a limited duration of
action (less than 5 hours) but it contributes to the decrease
in demand for systemic analgesics thereafter. Nevertheless,
this result suggests that a continuous parietal inﬁltration
could be adapted to extend the duration of analgesia to the
whole painful postoperative period. The use of this analgesic
technique does not lead to any increase in wound dehiscence
or infection.
On the other hand, the continuous administration of
local anaesthetic into the surgical wound can be more res-
trictive because the dressings need to be changed more
frequently, because of leakage of the anaesthetic solution
from the wound.
Numerous studies have shown the analgesic eﬃcacity
of ropivacaine inﬁltration into the surgical wound without
overdose, cardiovascular, or neurological toxicity [36–40].
However,thepeakbloodconcentrationisproportionaltothe
dose injected and the concentration of the solution used, as
has shown Wulf et al. in 1999 in his study on ilio-inguinal
nerve block using diﬀerent concentration of ropivacaine:
0.2%, 0.5%, or 0.75% in hernia repair surgery [22].
As far as ropivacaine toxicity is concerned, the epilepto-
genic threshold in man is unknown. In healthy volunteers,
after intravenous infusion of ropivacaine, neurological signs
appear with concentrations of 4300ng ± 600ng/mL (3400–
5300ng/mL). The peak is obtained after 13–15 minutes of
infusion, while it is obtained after 20 minutes for epidu-
ral analgesia and 21(± 9) minutes after intercostal nerve
block.6 Anesthesiology Research and Practice
Fromamongallthetechniquesofpostoperativeanalgesia
presented here, the inﬁltration of ropivacaine into the
Pfannenstiel incision represents the technique best adapted
to our practice, because of its indisputable eﬃcacy and the
simplicity and ease of realisation by all our obstetricians.
It favorises early mobility in the patients, from the 6th–
8th postoperative hour, thus allowing the sectioned mothers
to visit their babies sooner in the case of premature births
where the neonates are often in intensive care units. The
mother-child contact can thus be established earlier and this
contributes to their psychologic well-being.
Early mobility leads to more rapid intestinal activity and
so, to more rapid oral intake of liquids and solids. In our
hospital all patients who have undergone elective Caesarean
section and who have no bleeding or digestive complications
are fed 8 hours after surgery.
6. Conclusion
Postoperative inﬁltration of the surgical incision in Cae-
sarean section with ropivacaine 7.5mg/mL gives eﬀective
analgesia for several hours and decreases systemic analgesic
consumption. This technique could be considered as an
integral part of the analgesic protocol in patients scheduled
for Caesarean section. It aims to give optimal pain relief with
minimal side eﬀects, without interfering with the mother-
child relationship, allowing breast feeding and favorising
postoperative rehabilitation.
Our study has shown no surgical postoperative compli-
cation related to this technique.
Since this study, the protocol has been applied by all
members of the obstetrical team for all Caesarean sections
performed under spinal or general anaesthesia, except in
cases of contraindications to the use of local anaesthetics.
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